LM

Ladarpat Mohan Subramanya Mahesh Kumar

Active Director Director DIN 09833293
DIN 09833293 First appointment Dec 2022 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Ladarpat Mohan Subramanya Mahesh Kumar

Data last updated:

Ladarpat Mohan Subramanya Mahesh Kumar is a Director at Glorison Pharmaceuticals Private Limited (since 2022). The company operates in Healthcare.

DIN 09833293
Primary Designation Director
Industry Healthcare
First Appointment 21 Dec 2022
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Dec 20222022Active

Board colleagues of Ladarpat Mohan Subramanya Mahesh Kumar

Directorship timeline

Open interactive timeline →
Glorison Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ladarpat Mohan Subramanya Mahesh Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ladarpat Mohan Subramanya Mahesh Kumar

Ladarpat Mohan Subramanya Mahesh Kumar currently holds 1 directorship: Glorison Pharmaceuticals Private Limited (Director, since 21 Dec 2022).

Ladarpat Mohan Subramanya Mahesh Kumar was first appointed on 21 Dec 2022 as Director at Glorison Pharmaceuticals Private Limited.

The current boards of Ladarpat Mohan Subramanya Mahesh Kumar's companies include Nagaraja Nagamani (Glorison Pharmaceuticals Private Limited), Rajendrani Chattaraj (Glorison Pharmaceuticals Private Limited), Ramesh Praveen (Glorison Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available